No Data
No Data
Express News | Avalo Therapeutics - Garry Neil to Remain as CEO and Board Member
Express News | Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
Press Release: Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
Stifel Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $36
This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avalo Therapeutics Shares Are Trading Higher After Jefferies Initiated Coverage on the Stock With a Buy Rating and Announced a $23 Price Target. Also, Stifel Initiated Coverage on the Stock With a Buy Rating and Announced a $36 Price Target.